NASDAQ · MBLY

Mobileye Global Inc.

$8.01 -$0.04 (-0.50%) 1D Pre-market

Key Metrics

$2.03B
Market cap
P/E · TTM
$2.01B
Revenue · TTM
−$4.11B
Net income
EPS · TTM $-5.06
Dividend yield
Free cash flow $473.00M
Beta · 1Y 2.17
EBITDA · TTM −$4.08B
Gross margin 48.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 23
    The stock moved -14.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 23
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 30
    The stock moved +16.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 30
  • Mar 30
    From its Feb 11 high, the share price fell 32%.

    Peak close $9.63 on Feb 11; trough close $6.56 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -32%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.03B
Enterprise value
Shares outstanding252.4M
52-wk range$6.47 – $15.81
Avg volume · 20D4.8M
Net cash
Book value / share$10.05
IndustryServices-Prepackaged Software
ExchangeNASDAQ
About Mobileye Global Inc.
IPO dateOct 26, 2022
Employees4200

Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.01
P/FCF4.30
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 48.3%
Operating -206.6%
Net -204.0%
FCF 23.5%
ROE / ROIC -40.6% · -59.1%

Financial Health

Current ratio4.76
Quick ratio4.03
Debt / equity
Debt / EBITDA
Net cash
Working capital$1.57B

Cash Flow · TTM

Operating CF $568.00M
Capex −$95.00M
Free cash flow $473.00M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

-0.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-28 · computed by TickerWolf from SEC filings